ESC 2024 | SCOFF Trial: Fasting or No Fasting before Cardiac Catheterization Procedures

Millions of people undergo either diagnostic or therapeutic coronary procedures that require sedation. The aim of this study was to assess whether food restriction is necessary before sedation in these procedures. 

This was a randomized study in centers of Australia. Patients were randomly assigned 1:1 to two groups: the fasting group (6 hours with no solid food and 2 without any liquids) and the no restriction group (habitual diet).

The primary outcome was a composite of events including aspiration pneumonia, hypotension, hyper and hypo glycaemia. 

716 patients were included, mean age 69, 35% women. Primary end point occurred in 19.1% of the fasting group and 12% of the regular diet group. Upon intention to treat analysis, the net difference was -5.2% in favor of the no fast group, confirming non inferiority for this strategy.

Read also: ESC 2024 | SENIOR RITA: Invasive Strategy for Elderly Patients with ACS.

As regards patient satisfaction, it was significantly higher in the no fast group (15±4.3 vs. 11±4.0 satisfaction).

This study, together with the CHOW-NOW, TONIC and Fast-CIED studies, shows there is solid evidence in favor of the lack of benefit of fasting prior these kind of procedures. 

Presented by David Ferreia at Hot-Line Sessions, ESC Congress 2024, August 30 thru September 2, London, England  


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...

ACC 2026 | STEMI-Door To Unload: Unloading with Impella before PCI did not reduce infarct size in anterior STEMI

Anterior ST-segment elevation myocardial infarction (STEMI) remains associated with a high incidence of heart failure and mortality, even in the era of early reperfusion....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...